# The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis

> **NCT05664568** · PHASE2 · UNKNOWN · sponsor: **Western Sydney Local Health District** · enrollment: 30 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **DRUG:** Cephalexin
- **DRUG:** Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet
- **OTHER:** Standard of care treatment of tuberculosis

## Key facts

- **NCT ID:** NCT05664568
- **Lead sponsor:** Western Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2024-07
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664568, "The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05664568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*